Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Prostate Cancer

Free Subscription Articles published in AJR Am J Roentgenol Retrieve available abstracts of 15 articles: HTML format

Single Articles

March 2025
1. SPILSETH B
   Moving Towards Widespread Adoption of Prostate Cancer Screening With MRI: Questions Remaining for Optimization.
   AJR Am J Roentgenol. 2025 Mar 12. doi: 10.2214/AJR.25.32892.
   PubMed    
   
   
   February 2025
2. SCHOOTS IG, Haider MA, Punwani S, Padhani AR, et al
   MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening.
   AJR Am J Roentgenol. 2025 Feb 19. doi: 10.2214/AJR.24.32588.
   PubMed     Abstract available
   
   
   December 2024
3. LEWIS S, Rastinehad AR
   Beyond the AJR: Prostate Cancer Screening-Safe Omission of Biopsy in Patients With Negative MRI and the Need for High-Quality Imaging Standards.
   AJR Am J Roentgenol. 2024 Dec 11. doi: 10.2214/AJR.24.32431.
   PubMed    
   
   
   May 2024
4. SAVIR-BARUCH B, Parent E
   Beyond the AJR: PET/MRI Using (68)Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment.
   AJR Am J Roentgenol. 2024 May 15. doi: 10.2214/AJR.24.31412.
   PubMed    
   
   
   April 2024
5. DIAS AB, Chang SD, Fennessy FM, Ghafoor S, et al
   New Prostate MRI Scoring Systems (PI-QUAL, PRECISE, PI-RR, and PI-FAB): AJR Expert Panel Narrative Review.
   AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.30956.
   PubMed     Abstract available
   
   
   March 2024
6. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
   Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31168.
   PubMed    
   
   
   
7. TAKAHASHI T
   Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31070.
   PubMed    
   
   
   
8. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
   Reply to "Is PI-RADS Ready for Biparametric Prostate MRI?".
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31169.
   PubMed    
   
   
   
9. DANA J, Reinhold C, Gauvin S
   Is PI-RADS Ready for Biparametric Prostate MRI?
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31094.
   PubMed    
   
   
   February 2024
10. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    PubMed     Abstract available
    
    
    January 2024
11. LAWRENCE EM
    Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version 2.0 and Version 2.1.
    AJR Am J Roentgenol. 2024;222:e2330325.
    PubMed    
    
    
    December 2023
12. BIROSH A, Miranda ES, Breau RH, McInnes MDF, et al
    Multiparametric Versus Biparametric Prostate MRI: Comparison of NPV for Clinically Significant Prostate Cancer.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30496.
    PubMed    
    
    
    October 2023
13. THAMPY R, Spilseth B
    Beyond the AJR: Increased Use of Prostate MRI Before Biopsy Reduces Biopsy Frequency Without Compromising Detection of Aggressive Cancer.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.30407.
    PubMed    
    
    
    
14. TAN N, Pollock JR, Margolis DJA, Padhani AR, et al
    Management of Patients With a Negative Multiparametric Prostate MRI Examination: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.29969.
    PubMed     Abstract available
    
    
    September 2023
15. YILMAZ EC, Lin Y, Belue MJ, Harmon SA, et al
    PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29964.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.